Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion

Pediatrics

Volumn 117, Issue 3, 2006, Pages 603-608

  Van Heerbeek, Niels ^a   Straetemans, Masja ^b   Wiertsema, Selma P ^c   Ingels, Koen J A O ^a   Rijkers, Ger T ^c   Schilder, Anne G M ^c   Sanders, Elisabeth A M ^c   Zielhuis, Gerhard A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Conjugate vaccine; Effusion; Otitis media; Pneumococcal

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; PNEUMUNE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG; 23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; BACTERIAL POLYSACCHARIDE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; IMMUNOGLOBULIN M; MENINGOCOCCUS VACCINE; VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SECRETORY OTITIS MEDIA; VACCINATION; BLOOD; CHILD; IMMUNOLOGY; MICROBIOLOGY; MIDDLE EAR VENTILATION; RISK FACTOR; STREPTOCOCCUS INFECTION;

CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MENINGOCOCCAL VACCINES; MIDDLE EAR VENTILATION; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; RECURRENCE; RISK FACTORS; VACCINES, CONJUGATE;

EID: 33645037912     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0940     Document Type: Article

References (27)

1. Zielhuis GA, Rach GH, Van Den Broek P. The occurrence of otitis media with effusion in Dutch pre-school children. Clin Otolaryngol. 1990;15:147-153
2. Zielhuis GA, Rach GH, Van Den Broek P. The natural course of otitis media with effusion in preschool children. Eur Arch Otorhinolaryngol. 1990;247:215-221
3. Stenstrom C, Bylander Groth A, Ingvarsson L. Eustachian tube function in otitis-prone and healthy children. Int J Pediatr Otorhinolaryngol. 1991;21:127-138
4. Sade J, Ar A. Middle ear and auditory tube: middle ear clearance, gas exchange, and pressure regulation. Otolaryngol Head Neck Surg. 1997;116:499-524
5. Falk B, Magnuson B. Evacuation of the middle ear by sniffing: a cause of high negative pressure and development of middle ear disease. Otolaryngol Head Neck Surg. 1984;92:312-318
6. Straetemans M, Van Heerbeek N, Tonnaer EL, Ingels K, Rijkers GT, Zielhuis GA. A comprehensive model for the aetiology of otitis media with effusion. Med Hypotheses. 2001;57:784-791
7. Bennett KE, Haggard MP, Silva PA, Stewart IA. Behaviour and developmental effects of otitis media with effusion into the teens. Arch Dis Child. 2001;85:91-95
8. McCormick DP, Baldwin CD, Klecan-Aker JS, Swank PR, Johnson DL. Association of early bilateral middle ear effusion with language at age 5 years. Ambul Pediatr. 2001;1:87-90
9. Roberts JE, Burchinal MR, Zeisel SA. Otitis media in early childhood in relation to children's school-age language and academic skills. Pediatrics. 2002;110:696-706
10. Paradise JL. Otitis media and child development: should we worry? Pediatr Infect Dis J. 1998;17:1076-1083
11. Gok U, Bulut Y, Keles E, Yalcin S, Doymaz MZ. Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions. Int J Pediatr Otorhinolaryngol. 2001;60:49-54
12. Jero J, Virolainen A, Salo P, Leinonen M, Eskola J, Karma P. PCR assay for detecting Streptococcus pneumoniae in the middle ear of children with otitis media with effusion. Acta Otolaryngol. 1996;116:288-292
13. Giebink GS, Juhn SK, Weber ML, Le CT. The bacteriology and cytology of chronic otitis media with effusion. Pediatr Infect Dis. 1982;1:98-103
14. Straetemans M, Sanders EA, Veenhoven RH, Schilder AG, Damoiseaux RA, Zielhuis GA. Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media. Pediatr Infect Dis J. 2003;22:515-524
15. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet. 2003;361:2189-2195
16. Straetemans M, Palmu A, Auranen K, Zielhuis GA, Kilpi T. The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age. Int J Pediatr Otorhinolaryngol. 2003;67:1235-1242
17. Engel J, Anteunis L, Volovics A, Hendriks J, Marres E. Prevalence rates of otitis media with effusion from 0 to 2 years of age: healthy-born versus high-risk-born infants. Int J Pediatr Otorhinolaryngol. 1999;47:243-251
18. Van Heerbeek N, Ingels KJ, Snik AF, Zielhuis GA. Reliability of manometric Eustachian tube function tests in children. Otol Neurotol. 2001;22:183-187
19. Sanders LA, Rijkers GT, Tenbergen-Meekes AM, Voorhorst-Ogink MM, Zegers BJ. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections. Pediatr Res. 1995;37:812-819
20. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-16
21. Palmu AA, Verho J, Jokinen J, Karma P, Kilpi TM. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J. 2004;23:732-738
22. Lipsitch M, Dykes JK, Johnson SE, et al. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine. 2000;18:2895-2901
23. McEllistrem MC, Adams J, Mason EO, Wald ER. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003;188:1679-1684
24. Obaro SK. Confronting the pneumococcus: a target shift or bullet change? Vaccine. 2000;19:1211-1217
25. Kilpi T, Ahman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis. 2003;37:1155-1164
26. Veenhoven RH, Bogaert D, Schilder AG, et al. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media. Clin Infect Dis. 2004;39:911-919
27. Tonnaer EL, Ingels KJ, Rijkers GT, Curfs JH. Antigenic as well as nonantigenic stimuli induce similar middle ear responses in the rat. Laryngoscope. 2003;113:322-327